The Emerging Role of the Fetal Insulin Receptor in Hormone-refractory Breast Cancer is a research paper published in Endocrinology (2021). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Cancer Institute
Grant: 2P30-CA077598
National Cancer Institute
Grant: 1R01CA237000-01A1
Mayo Clinic Breast Cancer SPORE
Grant: 5P50CA116201
National Institutes of Health
Grant: 5P50CA116201-03
Developmental Research Program
National Institutes of Health
Grant: 5P30CA077598-08
Cancer Center Support Grant P30 CA77598-06
Fields of Study
Keywords
Sustainable Development Goals